• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[俄罗斯联邦欧洲部分幽门螺杆菌的抗生素耐药性:初步结果]

[Antibiotic resistance of Helicobacter pylori in the European part of the Russian Federation: first results].

作者信息

Maev I V, Andreev D N, Govorun V M, Ilina E N, Kucheryavyy Y A, Oganesian T S, Melnikova E V, Zayratyants O V, Parfenova T V, Dzhedzheia L V, Kirillova N V, Maevskaya E A, Fomenko A K, Lobanova E G, Zaborovskii A V, Kriukov K A

机构信息

Yevdokimov Moscow State University of Medicine and Dentistry.

Federal Research And Clinical Center of Physical-Chemical Medicine Federal Medical Biological Agency.

出版信息

Ter Arkh. 2020 Sep 3;92(8):24-28. doi: 10.26442/00403660.2020.08.000761.

DOI:10.26442/00403660.2020.08.000761
PMID:33346458
Abstract

AIM

Determine the primary antibiotic resistance of Helicobacter pylori (H. pylori) strains isolated from patients living in the European part of the Russian Federation.

MATERIALS AND METHODS

As part of a clinical laboratory study, from 2015 to 2018, 27 gastrobiopsy samples obtained from H. pylori-infected patients were analyzed. H. pylori infection was verified using a rapid urease test or a 13C-urea breath test. The values of the minimum inhibitory concentration (MIC) of antibiotics were determined by the diffusion method using E-test strips (BioMerieux, France) according to the recommendations of the manufacturer. The sensitivity of the isolates was determined for 6 antibacterial drugs (amoxicillin, clarithromycin, metronidazole, levofloxacin, tetracycline, rifampicin).

RESULTS

According to the data obtained, resistance to amoxicillin was 0%, clarithromycin 11.1%, metronidazole 59.3%, levofloxacin 3.7%, tetracycline 0%, and rifampicin 14.8%. Dual resistance to clarithromycin and metronidazole was recorded in two isolates (7.4%).

CONCLUSION

Thus, the first results of the evaluation of H. pylori antibiotic resistance in the European part of the Russian Federation indicate a low resistance of the microorganism to clarithromycin and quite high to metronidazole.

摘要

目的

确定从俄罗斯联邦欧洲部分居民中分离出的幽门螺杆菌(H. pylori)菌株的主要抗生素耐药性。

材料与方法

作为一项临床实验室研究的一部分,在2015年至2018年期间,对从幽门螺杆菌感染患者身上获取的27份胃活检样本进行了分析。使用快速尿素酶试验或13C尿素呼气试验来验证幽门螺杆菌感染。根据制造商的建议,使用E-test试纸条(法国生物梅里埃公司)通过扩散法测定抗生素的最低抑菌浓度(MIC)值。测定了分离株对6种抗菌药物(阿莫西林、克拉霉素、甲硝唑、左氧氟沙星、四环素、利福平)的敏感性。

结果

根据获得的数据,对阿莫西林的耐药率为0%,克拉霉素为11.1%,甲硝唑为59.3%,左氧氟沙星为3.7%,四环素为0%,利福平为14.8%。在两个分离株中记录到对克拉霉素和甲硝唑的双重耐药(7.4%)。

结论

因此,俄罗斯联邦欧洲部分幽门螺杆菌抗生素耐药性评估的初步结果表明,该微生物对克拉霉素的耐药性较低,而对甲硝唑的耐药性相当高。

相似文献

1
[Antibiotic resistance of Helicobacter pylori in the European part of the Russian Federation: first results].[俄罗斯联邦欧洲部分幽门螺杆菌的抗生素耐药性:初步结果]
Ter Arkh. 2020 Sep 3;92(8):24-28. doi: 10.26442/00403660.2020.08.000761.
2
Dynamics of antimicrobial resistance of Helicobacter pylori isolates in the Smolensk region of Russian Federation.俄罗斯联邦斯摩棱斯克地区幽门螺杆菌分离株的抗菌药物耐药性动态。
Helicobacter. 2018 Dec;23(6):e12545. doi: 10.1111/hel.12545. Epub 2018 Oct 16.
3
Helicobacter pylori resistance to antibiotics before and after treatment: Incidence of eradication failure.治疗前后幽门螺杆菌对抗生素的耐药性:根除失败的发生率。
PLoS One. 2022 Apr 20;17(4):e0265322. doi: 10.1371/journal.pone.0265322. eCollection 2022.
4
Antibiotic resistance of isolated from patients in Nanjing, China: A cross-section study from 2018 to 2021.从中国南京患者中分离的 的抗生素耐药性:2018 年至 2021 年的横断面研究。
Front Cell Infect Microbiol. 2022 Sep 8;12:970630. doi: 10.3389/fcimb.2022.970630. eCollection 2022.
5
High incidence of antibiotic resistance amongst isolates of collected in Nottingham, UK, between 2001 and 2018.2001 年至 2018 年间,在英国诺丁汉收集的分离物中,抗生素耐药率很高。
J Med Microbiol. 2023 Nov;72(11). doi: 10.1099/jmm.0.001776.
6
Five-year sequential changes in secondary antibiotic resistance of Helicobacter pylori in Taiwan.台湾幽门螺杆菌继发性抗生素耐药性的五年连续变化
World J Gastroenterol. 2015 Oct 7;21(37):10669-74. doi: 10.3748/wjg.v21.i37.10669.
7
[Helicobacter pylori resistance in the Russian Federation: a meta-analysis of studies over the past 10 years].[俄罗斯联邦幽门螺杆菌耐药性:过去10年研究的荟萃分析]
Ter Arkh. 2020 Dec 26;92(11):24-30.
8
The effect of previous eradication failure on antibiotic resistance of Helicobacter pylori: A retrospective study over 8 years in Beijing.既往根除失败对幽门螺杆菌耐药性的影响:北京 8 年回顾性研究。
Helicobacter. 2021 Aug;26(4):e12804. doi: 10.1111/hel.12804. Epub 2021 Apr 16.
9
Antibiotic resistance of Helicobacter pylori in Chinese children: A multicenter study from 2016 to 2023.中国儿童幽门螺杆菌的抗生素耐药性:一项 2016 年至 2023 年的多中心研究。
Helicobacter. 2024 Jan-Feb;29(1):e13038. doi: 10.1111/hel.13038. Epub 2023 Nov 20.
10
Detection of Helicobacter pylori by invasive tests in adult dyspeptic patients and antibacterial resistance to six antibiotics, including rifampicin in Turkey. Is clarithromycin resistance rate decreasing?在土耳其成年消化不良患者中通过侵入性检测法检测幽门螺杆菌以及对包括利福平在内的六种抗生素的抗菌耐药性。克拉霉素耐药率是否在下降?
Turk J Med Sci. 2021 Jun 28;51(3):1445-1464. doi: 10.3906/sag-2101-69.

引用本文的文献

1
Antibiotic Resistance in Russia: A Systematic Review and Meta-Analysis.俄罗斯的抗生素耐药性:系统评价与荟萃分析
Antibiotics (Basel). 2025 May 19;14(5):524. doi: 10.3390/antibiotics14050524.
2
First insight into the whole genome sequence variations in clarithromycin resistant Helicobacter pylori clinical isolates in Russia.首次深入研究俄罗斯克拉霉素耐药幽门螺杆菌临床分离株的全基因组序列变异。
Sci Rep. 2024 Aug 29;14(1):20108. doi: 10.1038/s41598-024-70977-4.
3
infection in humans and phytotherapy, probiotics, and emerging therapeutic interventions: a review.
人类感染与植物疗法、益生菌及新兴治疗干预措施:综述
Front Microbiol. 2024 Jan 10;14:1330029. doi: 10.3389/fmicb.2023.1330029. eCollection 2023.
4
The prevalence of clarithromycin-resistant isolates: a systematic review and meta-analysis.克拉霉素耐药分离株的流行率:系统评价和荟萃分析。
PeerJ. 2023 Mar 30;11:e15121. doi: 10.7717/peerj.15121. eCollection 2023.